Biotech | March 22, 2022
Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Successful proposals will secure fully funded postdoctoral research positions
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Subscribe To Our Newsletter & Stay Updated
